potent macrocyclic PCSK9 PPI inhibitor

1000x optimization of biochem. activity

from mRNA display screen and SBDD

J. Med. Chem., 2020, Nov. 10, 2020

Merck, PA + NJ / UCB Ra Pharma, MA

Merck/UCB/Ra Pharma macrocyclic PCSK9 protein-protein interaction (PPI) inhibitor


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks